LeoclanLEOCLAN Co.,Ltd.7681東証スタンダード卸売業FY ending Sep 2025, consolidated, J-GAAP

Leoclan FY ending Sep 2019 results

About 97% of Leoclan's sales come from Total medical solution business, with Remote image diagnosis service business and Food service making up much of the rest.

Out of every ¥100 of sales, about ¥3 is left as operating profit.

Where the money goes

Where ¥100 of sales goes

For every ¥100 Leoclan sells, how much goes where, and how much is kept.

FY ending Sep 2019
Cost of sales
¥91
SG&A
¥6
Operating profit
¥3
Net profit kept
¥2

Margin funnel (derived from reported values)Gross margin 9.3% → Operating margin 3.3% → Net margin 2.0%

Which businesses earn the money

Revenue by business segment, and the profit each one keeps.

FY ending Sep 2019

Profit by segment

※ Segment figures include inter-segment sales and do not sum to the company total

Sources

Show source documents (3)
  • EDINET (FSA Japan)

    有価証券報告書-第23期(2022/10/01-2023/09/30)

    ID S100SHP12023-12-21Open
  • EDINET (FSA Japan)

    有価証券報告書-第21期(令和2年10月1日-令和3年9月30日)

    ID S100N3F72021-12-23Open
  • EDINET (FSA Japan)

    有価証券報告書-第20期(令和1年10月1日-令和2年9月30日)

    ID S100KF0O2020-12-24Open

Extracted from XBRL: 47 / Derived from other figures: 2

Spotted an error? Report it (corrections keep the original record)

Other periods

Analyze this page with AI

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.